A business professional shakes the hand of a doctor, surrounded by nurses, all smiling.
THE CHALLENGE

Le fossé entre l’autorisation et l’accès

Une décision réglementaire favorable constitue la première étape d’un lancement au Royaume-Uni. Le NHS fonctionne selon un système à plusieurs niveaux : les recommandations du NICE priment sur la politique de passation de marchés du NHS England, les Integrated Care Boards (ICB) et les listes de médicaments de chaque hôpital, chacun ayant son propre calendrier,ses propres critères et ses propres décideurs. Sans relations existantes à aucun de ces niveaux, un nouvel entrant sur le marché doit s’y retrouver simultanément.

STEP 1

NICE guidelines

national appraisal
STEP 2

NHS England

procurement policy
STEP 3

ICBs

regional budgets
STEP 4

Hospital drug lists

local formularies

What first-time UK entrants run into

Outsourced teams, tailored to your launch

Field sales reps, market access specialists, MSLs, nurses or pharmacists: CHASE recruits, employs and manages your UK team under your brand and your strategy, and handles personnel admin, employment risk and compliance. Most teams are ready within six weeks.

DERMATOLOGY BRAND CASE STUDY

An entire UK field team rebuilt from scratch: recruited, assessed and mobilised in 4.5 weeks, with four members retained on their existing terms.

4.5 wks

to mobilise the team

8

new team members

100%

roles filled & trained

98.3%

client satisfaction
NHS ACCESS

Access to the NHS from day one

Our market access and clinical specialists have spent their careers with NICE, ICBs and NHS drug-list committees. We know what it takes at a local level to turn a positive national decision into real patient access, and we bring the relationships to make it happen.

PHARMA + NHS TRUST CASE STUDY

A local specialist clinical service built from scratch, fully operational within three months of approval.

3mo

to fully operational

Up to 2 yrs

faster to first biologic treatment

2 → 1

hospital visits into one appointment

Proven where it counts

3mo

to fully operational

Up to 2 yrs

faster to first biologic treatment

2 → 1

hospital visits into one appointment
trusted by global pharma and medtech
A man smiling at his computer